P135 Real-world effectiveness and safety of ustekinumab for the treatment of crohn’s: the Scottish ustekinumab cohort
Published: Jan 1, 2021
Abstract
Introduction
Ustekinumab (UST) is an anti-IL12/23 biologic licensed for the treatment of moderate to severe Crohn’s disease (CD). The aims of this study were to establish the long-term real-world effectiveness and safety of UST for the treatment of CD in a large UK cohort.Methods
This was a multicentre retrospective cohort study including 8 NHS health-boards in Scotland. Patients treated with UST between Nov 2015 and Jun 2019...Paper Details
Title
P135 Real-world effectiveness and safety of ustekinumab for the treatment of crohn’s: the Scottish ustekinumab cohort
Published Date
Jan 1, 2021
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History